MDGL - Madrigal Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

MDGL is currently covered by 10 analysts with an average price target of $508.46. This is a potential upside of $89.56 (21.38%) from yesterday's end of day stock price of $418.9.

Madrigal Pharmaceuticals's activity chart (see below) currently has 205 price targets and 146 ratings on display. The stock rating distribution of MDGL is 5% HOLD and 95% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 88.39% with an average time for these price targets to be met of 458.44 days.

Highest price target for MDGL is $590, Lowest price target is $392, average price target is $504.4.

Most recent stock forecast was given by YASMEEN RAHIMI from PIPER SANDLER on 15-Oct-2025. First documented stock forecast 29-Oct-2014.

Currently out of the existing stock ratings of MDGL, 1 are a HOLD (5%), 19 are a BUY (95%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$540

$121.1 (28.91%)

$400

20 days ago
(15-Oct-2025)

15/16 (93.75%)

$106.42 (24.54%)

366

Buy

$590

$171.1 (40.85%)

$400

25 days ago
(10-Oct-2025)

11/13 (84.62%)

$160.65 (37.42%)

350

Buy

$560

$141.1 (33.68%)

$460

1 months 6 days ago
(29-Sep-2025)

10/14 (71.43%)

$116.9 (26.38%)

261

Buy

$526

$107.1 (25.57%)

$428

1 months 23 days ago
(12-Sep-2025)

14/15 (93.33%)

$93.78 (21.70%)

378

Buy

$554

$135.1 (32.25%)

$390

2 months 9 days ago
(26-Aug-2025)

3/4 (75%)

$129.14 (30.40%)

277

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is MDGL (Madrigal Pharmaceuticals) average time for price targets to be met?

On average it took 458.44 days on average for the stock forecasts to be realized with a an average price target met ratio 88.39

Which analyst has the current highest performing score on MDGL (Madrigal Pharmaceuticals) with a proven track record?

JONATHAN WOLLEBEN

Which analyst has the most public recommendations on MDGL (Madrigal Pharmaceuticals)?

Jonathan Wolleben works at JMP and has 12 price targets and 9 ratings on MDGL

Which analyst is the currently most bullish on MDGL (Madrigal Pharmaceuticals)?

Jay Olson with highest potential upside - $171.1

Which analyst is the currently most reserved on MDGL (Madrigal Pharmaceuticals)?

Matthew Luchini with lowest potential downside - -$307.9

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?